Brian I. Carr
Impact in
- Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Cancer Research top 0.5%
Papers in
- Hepatology 166
- Hepatocellular Carcinoma Treatment and Prognosis 129
- Liver physiology and pathology 44
- Liver Disease and Transplantation 24
-
- Cancer, Lipids, and Metabolism 34
- Cancer, Hypoxia, and Metabolism 26
- Co-authors
- Vito GuerraSiddhartha KarJames H. OliverThomas E. StarzlR L BaronZiqiu WangJennifer L. SteelShunzaburo Iwatsuki
- Journals
- Journal of Cellular Physiology (23 papers)Hepatology (17 papers)Journal of Clinical Oncology (14 papers)Digestive Diseases and Sciences (12 papers)Cancer (10 papers)
- Partner nations
- United StatesItalyTürkiye
In The Last Decade
Brian I. Carr
362 papers receiving 12.7k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Hepatology 6.6k
- Cancer Research 1.7k
- Oncology 3.1k
- Epidemiology 3.3k
- Toxicology 260
Countries citing papers authored by Brian I. Carr
This map shows the geographic impact of Brian I. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian I. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian I. Carr more than expected).
Fields of papers citing papers by Brian I. Carr
This network shows the impact of papers produced by Brian I. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian I. Carr. The network helps show where Brian I. Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian I. Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 16 | |
| 13 | 2012 | 50 | |
| 14 | H32, a new non-quinone vitamin K sulfone analog, inhibits tumor cell growth by MAPK activation | 2006 | 1 |
| 15 | 1996 | 1 | |
| 16 | Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. | 1995 | 55 |
| 17 | 1995 | 31 | |
| 18 | 1991 | 206 | |
| 19 | 1985 | 33 | |
| 20 | 1983 | 4 |
About Brian I. Carr
Brian I. Carr is a scholar working on Hepatology, Cancer Research, Oncology, Epidemiology and Toxicology, having authored 375 papers that have together received 13.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (129 papers), Liver Disease Diagnosis and Treatment (84 papers), Liver physiology and pathology (44 papers), Cancer, Lipids, and Metabolism (34 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Protein Tyrosine Phosphatases (27 papers), Cancer, Hypoxia, and Metabolism (26 papers) and Liver Disease and Transplantation (24 papers). The work is most often cited by research in Hepatology (6.6k citations), Cancer Research (1.7k citations), Oncology (3.1k citations), Epidemiology (3.3k citations) and Toxicology (260 citations). Brian I. Carr has collaborated with scholars based in United States, Italy and Türkiye. Frequent co-authors include Vito Guerra, Siddhartha Kar, James H. Oliver, Thomas E. Starzl, R L Baron, Ziqiu Wang, Jennifer L. Steel, Shunzaburo Iwatsuki, Meifang Wang and Riad Salem. Their work appears in journals such as Journal of Cellular Physiology, Hepatology, Journal of Clinical Oncology, Digestive Diseases and Sciences and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.